Warp, you are correct. The intent is to show that ADXS was going through similar situation as AMBS. They did a RS and the stock wobbled around some but has taken a definite north turn. Both of these are bio-tech stocks and have had to seek financing and similar paths. I am much heavier invested in AMBS but like the prospects of ADXS over the long haul (and many people who might get various forms of cancer will appreciate what they are doing).